Pharmaceutical groups want more clarity on continuous manufacturing guideline
Regulatory News
BiologicsBiotechnologyChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy